Osimertinib
Medicine
Lung cancer
Epidermal growth factor receptor
Oncology
Internal medicine
Acquired resistance
Tyrosine-kinase inhibitor
Mutant
Tyrosine kinase
Cohort
non-small cell lung cancer (NSCLC)
Receptor
Cancer
Gene
Genetics
Biology
Erlotinib
A549 cell
